Skip to main content

Table 1 Factors associated with active infection in HIV/AIDS patients

From: Effectiveness of dolutegravir-based treatment among HIV/AIDS patients in Nkembo Outpatient Treatment Center, Gabon

Variable

Univariate analysis

Multivariate analysis

OR (95% CI)

P-value

aOR (95% CI)

P-value

Sex

Male

Female

1.1 (0.6–1.9)

-

0.39

1.1 (0.7–1.7)

-

0.636

Age group

18–24

25–34

35–44

≥ 45

-

1.5 (0.4–4.9)

1.2 (0.4–3.6)

-

0.579

0.487

-

1.2 (0.7–1.9)

1.1 (0.70–1.9)

-

0.569

0.698

Marital status

Single

Married

4.5 (2.1–9.7)

-

0.0001

2.1 (1.4–3.1)

-

0.001

CD4+

˂ 200 cel/mm3

≥ 200 cel/mm3

3.5 (2-6.1)

-

0.0001

1.9 (1.2–2.8)

-

0.001

Duration of treatment

6–12 months

˃12 months

-

5.1 (2.7–9.4)

0.0001

-

2.4 (1.5–3.4)

0.0001

  1. OR: Odds Ratio; aOR: Adjusted Odds Ratio; 95% CI: 95% confidence interval